Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Blockade of Kv1.3 Potassium Channels Inhibits Differentiation and Granzyme B Secretion of Human CD8+ T Effector Memory Lymphocytes.
Signaling mechanisms regulating myelination in the central nervous system.
Autoimmune Thyroid Disease in the Use of Alemtuzumab for Multiple Sclerosis: A Review.
Pro-Inflammatory Cytokines Reduce the Proliferation of NG2 Cells and Increase Shedding of NG2 In Vivo and In Vitro.
Osmotic demyelination syndrome in Intensive Care Unit.
The active form of vitamin D transcriptionally represses the Smad7 signaling and activates ERK to inhibit the differentiation of a inflammatory T helper cell subset and suppress experimental autoimmune encephalomyelitis.
Behavioural changes observed in demyelination model shares similarities with white matter abnormalities in humans.
Secondary Health Conditions in Individuals With Multiple Sclerosis: A Cross-Sectional Web-Based Survey Analysis.
Level of education and multiple sclerosis risk after adjustment for known risk factors: The EnvIMS study.
B Cells and Autoantibodies in Multiple Sclerosis.
Masquerading optic neuritis.
Pregnancy outcomes in aquaporin-4-positive neuromyelitis optica spectrum disorder.
A preliminary validation of the brief international cognitive assessment for multiple sclerosis (BICAMS) tool in an Irish population with multiple sclerosis (MS).
Response to IV immunoglobulin in a case of osmotic demyelination syndrome.
Evaluating Sativex® in Neuropathic Pain Management: A Clinical and Neurophysiological Assessment in Multiple Sclerosis.
Diagnostic tools for assessment of urinary dysfunction in MS patients without urinary disturbances.
Venous Hemodynamic Insufficiency Severity Score variation after endovascular treatment of chronic cerebrospinal venous insufficiency.
Investigation of outer cortical magnetisation transfer ratio abnormalities in multiple sclerosis clinical subgroups.
Relapsing inappropriate antidiuretic hormone secretion in an anti-aquaporin-4 antibody positive paediatric patient.
Redefining Self: Patients' Decision Making About Treatment for Multiple Sclerosis.
Jitter of corticospinal neurons during repetitive transcranial magnetic stimulation. Method and possible clinical implications.
Effect of the semen extract of Cuscuta chinensis on inflammatory responses in LPS-stimulated BV-2 microglia.
Benign-onset acute disseminated encephalomyelitis: a report on two cases.
The usefulness of brain MRI at onset in the differentiation of multiple sclerosis and seropositive neuromyelitis optica spectrum disorders.
Quantifying the local tissue volume and composition in individual brains with magnetic resonance imaging.
Pages
« first
‹ previous
…
473
474
475
476
477
478
479
480
481
…
next ›
last »